A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
Clinical trial NCT02207374 · COMPLETED
Trial details
- NCT number
- NCT02207374
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-04
- Primary completion
- 2016-02-27
- Enrollment
- 601
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.